Clinical PET/MR [0.03%]
临床PET/MR影像技术
Wolfgang Weber
Wolfgang Weber
Oncologic imaging has been a major focus of clinical research on PET/MR over the last 10 years. Studies so far have shown that PET/MR with 18F-Fluorodeoxyglucose (FDG) overall provides a similar accuracy for tumor staging as FDG PET/CT. The...
Clinical MR Biomarkers [0.03%]
临床磁共振生物标志物
Daniel Paech,Heinz-Peter Schlemmer
Daniel Paech
Non-invasive magnetic resonance imaging (MRI) techniques are increasingly applied in the clinic with a fast growing body of evidence regarding its value for clinical decision making. In contrast to biochemical or histological markers, the k...
Non-FDG PET/CT [0.03%]
非FDG PET/CT
Egesta Lopci,Stefano Fanti
Egesta Lopci
The major applications for molecular imaging with PET in clinical practice concern cancer imaging. Undoubtedly, 18F-FDG represents the backbone of nuclear oncology as it remains so far the most widely employed positron emitter compound. The...
Juliane Becker,Sarah M Schwarzenböck,Bernd J Krause
Juliane Becker
Molecular imaging with positron emission tomography (PET) using tumour-seeking radiopharmaceuticals has gained wide acceptance in oncology with many clinical applications. The hybrid imaging modality PET/CT (computed tomography) allows asse...
Dirk Grosenick,Christoph Bremer
Dirk Grosenick
Optical imaging offers a high potential for noninvasive detection and therapy of cancer in humans. Recent advances in instrumentation for diffuse optical imaging have led to new capabilities for the detection of cancer in highly scattering ...
Philipp Ritt,Torsten Kuwert
Philipp Ritt
The continuous development of SPECT over the past 50 years has led to improved image quality and increased diagnostic confidence. The most influential developments include the realization of hybrid SPECT/CT devices, as well as the implement...
Dimitrios Kapsokalyvas,Marc A M J van Zandvoort
Dimitrios Kapsokalyvas
Preclinical studies usually require high levels of morphological, functional, and biochemical information at subcellular resolution. This type of information cannot be obtained from clinical imaging techniques, such as MRI, PET/CT, or US. L...
Molecular Ultrasound Imaging [0.03%]
分子超声成像技术
Jasmin Baier,Anne Rix,Fabian Kiessling
Jasmin Baier
Contrast-enhanced ultrasound (CEUS) imaging is a valuable tool for preclinical and clinical diagnostics. The most frequently used ultrasound contrast agents are microbubbles. Besides them, novel nano-sized materials are under investigation,...
Sonja Schelhaas
Sonja Schelhaas
Understanding the (molecular) mechanisms underlying tumor progression is fundamental for developing and improving cancer diagnosis and therapy. Positron emission tomography (PET) is a method to non-invasively and longitudinally provide such...
Joanna Napp,Andrea Markus,Frauke Alves
Joanna Napp
The spatiotemporal determination of molecular events and cells is important for understanding disease processes, especially in oncology, and thus for the development of novel treatments. Equally important is the knowledge of the biodistribu...